You are here

Article info

Article menu
Download PDFPDF
Aetiology
Systematic review
Sublingual immunotherapy improves symptoms of allergical rhinoconjunctivitis and asthma

Authors

  1. Correspondence to: Dr Deborah A Gentile, Division of Allergy, Asthma and Immunology, Allegheny General Hospital, 320 E North Avenue, Pittsburgh, PA 15212, USA; dgentile{at}wpahs.org
View Full Text

Citation

Gentile DA
Sublingual immunotherapy improves symptoms of allergical rhinoconjunctivitis and asthma
BMJ Evidence-Based Medicine 2014;19:34-35.

Publication history

  • First published August 9, 2013.
Online issue publication 
November 21, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions